Sickle Cell Anemia
What's New
Last Posted: May 02, 2024
- Genetic Modifiers of Sickle Cell Anemia Phenotype in a Cohort of Angolan Children.
Catarina Ginete et al. Genes (Basel) 2024 15(4) - Dental caries in the permanent dentition and health-related quality of life among children and adolescents with sickle cell disease.
Vera Lúcia Duarte da Costa Mendes et al. Cien Saude Colet 2024 29(3) e06752023 - An update review of new therapies in sickle cell disease: the prospects for drug combinations.
Sanne Lugthart et al. Expert Opin Pharmacother 2024 - Blood Spotlight Review on Gene Therapy for Sickle Cell Disease.
Edward J Benz et al. Blood 2024 - Two-Dimensional Ultrasound Assessment of Long-Term Intra-Abdominal Organ Changes in Children with Sickle Cell Anemia during Steady State: A Comparative Study.
C S Nwosu et al. Niger J Clin Pract 2023 26(12) 1861-1867 - Newborn screening for sickle cell anemia in Antalya, Türkiye.
Zeynep Öztürk et al. Turk J Pediatr 2024 65(6) 959-963 - Sickle Cell Disease Approvals Include First CRISPR Gene Editing Therapy
E Harris, JAMA, January 3, 2024 - A Newborn Screening Program for Sickle Cell Disease in Murcia (Spain).
María Sánchez-Villalobos et al. Int J Neonatal Screen 2023 9(4) - Epidemiology of Glucose-6-Phosphate Dehydrogenase Deficiency in Arab Countries: Insights from a Systematic Review.
Abdulaziz S Alangari et al. J Clin Med 2023 12(20) - Why we need more Black blood donors to treat sickle cell anemia
SB Peter, CNN, June 27, 2023 - CRISPR in Public Health: The Health Equity Implications and Role of Community in Gene-Editing Research and Applications.
Andrew M Subica et al. Am J Public Health 2023 e1-e9 - Food Consumption of People with Sickle Cell Anemia in a Middle-Income Country.
Tamara Vilhena Teixeira et al. Nutrients 2023 15(6) - Iron Status in Sickle Cell Anemia: Deficiency or Overload?
Varsha P Patel et al. Cureus 2023 15(2) e35310 - Hydroxyurea for Children with Sickle Cell Disease in sub-Saharan Africa: A Summary of the Evidence, Opportunities, and Challenges.
Daniel Dexter et al. Pharmacotherapy 2023 - Creating an Automated Contemporaneous Cohort in Sickle Cell Anemia to Predict Survival After Disease-Modifying Therapy.
Cronin Robert M et al. Blood advances 2022 - Opportunity for pharmacogenetics testing in patients with sickle cell anemia.
Gallaway Katherine A et al. Pharmacogenomics 2022 - Sickle Cell Disease in Children and Adolescents: A Review of the Historical, Clinical, and Public Health Perspective of Sub-Saharan Africa and Beyond.
Egesa Walufu Ivan et al. International journal of pediatrics 2022 20223885979 - Transcript for Vital Signs Telebriefing: Children with sickle cell anemia are at risk for stroke and other complications
CDC, October 2022 - Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.
Snyder Angela B et al. Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) 2022 71(9) 1-18 - Vital Signs: Use of Recommended Health Care Measures to Prevent Selected Complications of Sickle Cell Anemia in Children and Adolescents — Selected U.S. States, 2019
LA Schieve et al, CDC, MMWR, September 20, 2022
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: